Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Table des matières
Afficher le documentAcknowledgements
Afficher le documentExecutive summary
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2. Sources of information and study methodology
Ouvrir ce répertoire et afficher son contenu3. Dissemination and uptake of the Guidelines
Ouvrir ce répertoire et afficher son contenu4. Basic characteristics of drug donations
Ouvrir ce répertoire et afficher son contenu5. Practical benefits as a result of the Guidelines
Afficher le document6. Drug donations which were hampered, delayed or cancelled
Ouvrir ce répertoire et afficher son contenu7. Experiences and opinions regarding the 12-month shelf-life requirement
Ouvrir ce répertoire et afficher son contenu8. Other suggestions to improve the Guidelines
Ouvrir ce répertoire et afficher son contenu9. How could donation practice be further improved?
Afficher le document10. Summary of recommendations
Afficher le document11. Postscript
Afficher le documentReferences
 

First-Year Experiences with the Interagency Guidelines for Drug Donations

WHO/EDM/PAR/2000.1
English only
Distribution: limited

Department of Essential Drugs and Medicines Policy
World Health Organization

Authors

Ms Radha Asher
Dr Robin Gray
Dr Hans Hogerzeil

Department of Essential Drugs and Medicines Policy
World Health Organization, Geneva

Quotation from an individual health institution:

We see the Guidelines as a help to us, to continue to provide essential services to as many patients as possible, and at reasonable cost. We also see the Guidelines as a necessary component in the development of a health care system that is sustainable, encouraging recipients and patients to take more responsibility in the management of health care delivery.

© World Health Organization 2000
________________________________________
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).
The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019